SANDPIPER THERAPEUTICS
LIVE

Serial Number

98942955

Owner

Sandpiper Therapeutics, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Jan 7, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SANDPIPER THERAPEUTICS Trademark

Serial Number: 98942955

SANDPIPER THERAPEUTICS is a trademark filed by Sandpiper Therapeutics, Inc. on January 7, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Sandpiper Therapeutics, Inc.

One Sansome Street, Suite 1650
San Francisco, CA 94104

Entity Type: 03

Trademark Details

Filing Date

January 7, 2025

Registration Date

Not Registered

Published for Opposition

August 26, 2025

Goods & Services

Pharmaceutical preparations for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; biological preparations for use in cell culture for medical purposes related to oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; therapeutic pharmaceuticals for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; biological therapies in the nature of pharmaceutical preparations for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases

research and development in the field of small molecule drug discovery for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; pharmaceutical products development in the fields of oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; scientific research for medical purposes in the fields of oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; pharmaceutical research and development services in the fields of oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; research and development of therapeutics for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; drug discovery services in the fields of oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; research and development in the field of precision medicine for use in oncology, immunology, cardiometabolic diseases, and cardiovascular diseases; medical and scientific research in the fields of oncology, immunology, cardiometabolic diseases, and cardiovascular diseases

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 14, 2026 EXRA
SOU EXTENSION 1 GRANTED
Apr 13, 2026 EX1G
SOU EXTENSION 1 FILED
Apr 13, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 13, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 21, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 26, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 20, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 18, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 18, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 18, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 18, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 1, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 1, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 1, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 17, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 29, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 7, 2025 MAFR
NEW APPLICATION ENTERED
Jan 7, 2025 NWAP